• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G/A filed by WalkMe Ltd. (Amendment)

    2/14/23 12:25:59 PM ET
    $WKME
    Computer Software: Prepackaged Software
    Technology
    Get the next $WKME alert in real time by email
    SC 13G/A 1 d271147dsc13ga.htm SC 13G/A SC 13G/A

     

     

    SECURITIES AND EXCHANGE COMMISSION

    WASHINGTON, D.C. 20549

     

     

    SCHEDULE 13G

    (Rule 13d-102)

    INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO § 240.13d-1

    (b), (c) AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO § 240.13d-2

    (Amendment No. 1)*

     

     

    WalkMe Ltd.

    (Name of Issuer)

    Ordinary Shares, no par value

    (Title of Class of Securities)

    M97628107

    (CUSIP Number)

    December 31, 2022

    (Date of Event Which Requires Filing of this Statement)

     

     

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

    ☐ Rule 13d-1(b)

    ☐ Rule 13d-1(c)

    ☒ Rule 13d-1(d)

     

    *

    The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

    The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     

     

     


    CUSIP NO. M97628107    13 G    Page 2 of 12 Pages

     

      1    

      NAMES OF REPORTING PERSONS

      Gemini Israel V Limited Partnership

     

      I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY):

      00-0000000

      2  

      CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)

      (a)  ☐        (b)  ☒ (1)

     

      3  

      SEC USE ONLY

     

      4  

      CITIZENSHIP OR PLACE OF ORGANIZATION

     

      Israel

    NUMBER OF

    SHARES

     BENEFICIALLY 

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH

       5    

      SOLE VOTING POWER

     

      0

       6  

      SHARED VOTING POWER

     

      7,652,748

       7  

      SOLE DISPOSITIVE POWER

     

      0

       8  

      SHARED DISPOSITIVE POWER

     

      7,652,748

      9    

      AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

      7,652,748

    10  

      CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)

     

      ☐

    11  

      PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

     

      9.1% (2)

    12  

      TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)

     

      PN

     

    (1)

    This Schedule 13G is filed on behalf of Gemini Israel V Limited Partnership (“Gemini V”), Gemini Capital Associates V LP (“Gemini Associates LP”), Gemini Capital Associates V GP, Ltd. (“Gemini Associates GP”), Gemini Partners Investors V L.P. (“Gemini Partners”), Gemini Israel Funds IV Ltd. (“Gemini Israel”), Menashe Ezra (“Ezra”) and Yossi Sela (“Sela”) (collectively, the “Reporting Persons”). Gemini Associates GP is the general partner of Gemini Associates LP, which is the general partner of Gemini V, and each of Gemini Associates GP and Gemini Associates LP may be deemed to beneficially own the ordinary shares of the issuer held by Gemini V. Gemini Israel is the general partner of Gemini Partners and may be deemed to beneficially own the ordinary shares of the issuer held by Gemini Partners. Ezra and Sela are the managing partners of Gemini Associates GP and Gemini Israel, and each of Ezra and Sela may therefore be deemed to beneficially own the ordinary shares of the issuer held by Gemini V and Gemini Partners. Each of Gemini Associates GP, Gemini Associates LP, Germini Israel, Ezra and Sela hereby disclaims beneficial ownership of the ordinary shares of the issuer held by Gemini V and Gemini Partners except to the extent of its or his pecuniary interest therein. The Reporting Persons may be deed to a be a “group” for purposes of Section 13 of the Securities and Exchange Act of 1934 and hereby expressly disclaim status as a “group” for purposes of this Schedule 13G.

    (2)

    Based on 83,754,006 of the Issuer’s ordinary shares outstanding as of December 31, 2021, as reported in the Issuer’s Annual Report on Form 20-F for the annual period ended December 31, 2021, filed with the Securities and Exchange Commission on March 24, 2022.


    CUSIP NO. M97628107    13 G    Page 3 of 12 Pages

     

      1    

      NAMES OF REPORTING PERSONS

      Gemini Capital Associates V L.P.

     

      I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY):

      00-0000000

      2  

      CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)

      (a)  ☐        (b)  ☒ (1)

     

      3  

      SEC USE ONLY

     

      4  

      CITIZENSHIP OR PLACE OF ORGANIZATION

     

      Israel

    NUMBER OF

    SHARES

     BENEFICIALLY 

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH

       5    

      SOLE VOTING POWER

     

      0

       6  

      SHARED VOTING POWER

     

      7,652,748

       7  

      SOLE DISPOSITIVE POWER

     

      0

       8  

      SHARED DISPOSITIVE POWER

     

      7,652,748

      9    

      AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

      7,652,748

    10  

      CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)

     

      ☐

    11  

      PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

     

      9.1% (2)

    12  

      TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)

     

      PN

     

    (1)

    This Schedule 13G is filed on behalf of Gemini Israel V Limited Partnership (“Gemini V”), Gemini Capital Associates V LP (“Gemini Associates LP”), Gemini Capital Associates V GP, Ltd. (“Gemini Associates GP”), Gemini Partners Investors V L.P. (“Gemini Partners”), Gemini Israel Funds IV Ltd. (“Gemini Israel”), Menashe Ezra (“Ezra”) and Yossi Sela (“Sela”) (collectively, the “Reporting Persons”). Gemini Associates GP is the general partner of Gemini Associates LP, which is the general partner of Gemini V, and each of Gemini Associates GP and Gemini Associates LP may be deemed to beneficially own the ordinary shares of the issuer held by Gemini V. Gemini Israel is the general partner of Gemini Partners and may be deemed to beneficially own the ordinary shares of the issuer held by Gemini Partners. Ezra and Sela are the managing partners of Gemini Associates GP and Gemini Israel, and each of Ezra and Sela may therefore be deemed to beneficially own the ordinary shares of the issuer held by Gemini V and Gemini Partners. Each of Gemini Associates GP, Gemini Associates LP, Germini Israel, Ezra and Sela hereby disclaims beneficial ownership of the ordinary shares of the issuer held by Gemini V and Gemini Partners except to the extent of its or his pecuniary interest therein. The Reporting Persons may be deed to a be a “group” for purposes of Section 13 of the Securities and Exchange Act of 1934 and hereby expressly disclaim status as a “group” for purposes of this Schedule 13G.

    (2)

    Based on 83,754,006 of the Issuer’s ordinary shares outstanding as of December 31, 2021, as reported in the Issuer’s Annual Report on Form 20-F for the annual period ended December 31, 2021, filed with the Securities and Exchange Commission on March 24, 2022.


    CUSIP NO. M97628107    13 G    Page 4 of 12 Pages

     

      1    

      NAMES OF REPORTING PERSONS

      Gemini Capital Associates V GP Ltd.

     

      I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY):

      00-0000000

      2  

      CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)

      (a)  ☐        (b)  ☒ (1)

     

      3  

      SEC USE ONLY

     

      4  

      CITIZENSHIP OR PLACE OF ORGANIZATION

     

      Israel

    NUMBER OF

    SHARES

     BENEFICIALLY 

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH

       5    

      SOLE VOTING POWER

     

      0

       6  

      SHARED VOTING POWER

     

      7,652,748

       7  

      SOLE DISPOSITIVE POWER

     

      0

       8  

      SHARED DISPOSITIVE POWER

     

      7,652,748

      9    

      AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

      7,652,748

    10  

      CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)

     

      ☐

    11  

      PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

     

      9.1% (2)

    12  

      TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)

     

      OO

     

    (1)

    This Schedule 13G is filed on behalf of Gemini Israel V Limited Partnership (“Gemini V”), Gemini Capital Associates V LP (“Gemini Associates LP”), Gemini Capital Associates V GP, Ltd. (“Gemini Associates GP”), Gemini Partners Investors V L.P. (“Gemini Partners”), Gemini Israel Funds IV Ltd. (“Gemini Israel”), Menashe Ezra (“Ezra”) and Yossi Sela (“Sela”) (collectively, the “Reporting Persons”). Gemini Associates GP is the general partner of Gemini Associates LP, which is the general partner of Gemini V, and each of Gemini Associates GP and Gemini Associates LP may be deemed to beneficially own the ordinary shares of the issuer held by Gemini V. Gemini Israel is the general partner of Gemini Partners and may be deemed to beneficially own the ordinary shares of the issuer held by Gemini Partners. Ezra and Sela are the managing partners of Gemini Associates GP and Gemini Israel, and each of Ezra and Sela may therefore be deemed to beneficially own the ordinary shares of the issuer held by Gemini V and Gemini Partners. Each of Gemini Associates GP, Gemini Associates LP, Germini Israel, Ezra and Sela hereby disclaims beneficial ownership of the ordinary shares of the issuer held by Gemini V and Gemini Partners except to the extent of its or his pecuniary interest therein. The Reporting Persons may be deed to a be a “group” for purposes of Section 13 of the Securities and Exchange Act of 1934 and hereby expressly disclaim status as a “group” for purposes of this Schedule 13G.

    (2)

    Based on 83,754,006 of the Issuer’s ordinary shares outstanding as of December 31, 2021, as reported in the Issuer’s Annual Report on Form 20-F for the annual period ended December 31, 2021, filed with the Securities and Exchange Commission on March 24, 2022.


    CUSIP NO. M97628107    13 G    Page 5 of 12 Pages

     

      1    

      NAMES OF REPORTING PERSONS

      Gemini Partners Investors V L.P.

     

      I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY):

      20-4456892

      2  

      CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)

      (a)  ☐        (b)  ☒ (1)

     

      3  

      SEC USE ONLY

     

      4  

      CITIZENSHIP OR PLACE OF ORGANIZATION

     

      Israel

    NUMBER OF

    SHARES

     BENEFICIALLY 

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH

       5    

      SOLE VOTING POWER

     

      0

       6  

      SHARED VOTING POWER

     

      77,300

       7  

      SOLE DISPOSITIVE POWER

     

      0

       8  

      SHARED DISPOSITIVE POWER

     

      77,300

      9    

      AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

      77,300

    10  

      CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)

     

      ☐

    11  

      PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

     

      0.1% (2)

    12  

      TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)

     

      PN

     

    (1)

    This Schedule 13G is filed on behalf of Gemini Israel V Limited Partnership (“Gemini V”), Gemini Capital Associates V LP (“Gemini Associates LP”), Gemini Capital Associates V GP, Ltd. (“Gemini Associates GP”), Gemini Partners Investors V L.P. (“Gemini Partners”), Gemini Israel Funds IV Ltd. (“Gemini Israel”), Menashe Ezra (“Ezra”) and Yossi Sela (“Sela”) (collectively, the “Reporting Persons”). Gemini Associates GP is the general partner of Gemini Associates LP, which is the general partner of Gemini V, and each of Gemini Associates GP and Gemini Associates LP may be deemed to beneficially own the ordinary shares of the issuer held by Gemini V. Gemini Israel is the general partner of Gemini Partners and may be deemed to beneficially own the ordinary shares of the issuer held by Gemini Partners. Ezra and Sela are the managing partners of Gemini Associates GP and Gemini Israel, and each of Ezra and Sela may therefore be deemed to beneficially own the ordinary shares of the issuer held by Gemini V and Gemini Partners. Each of Gemini Associates GP, Gemini Associates LP, Germini Israel, Ezra and Sela hereby disclaims beneficial ownership of the ordinary shares of the issuer held by Gemini V and Gemini Partners except to the extent of its or his pecuniary interest therein. The Reporting Persons may be deed to a be a “group” for purposes of Section 13 of the Securities and Exchange Act of 1934 and hereby expressly disclaim status as a “group” for purposes of this Schedule 13G.

    (2)

    Based on 83,754,006 of the Issuer’s ordinary shares outstanding as of December 31, 2021, as reported in the Issuer’s Annual Report on Form 20-F for the annual period ended December 31, 2021, filed with the Securities and Exchange Commission on March 24, 2022.


    CUSIP NO. M97628107    13 G    Page 6 of 12 Pages

     

      1    

      NAMES OF REPORTING PERSONS

      Gemini Israel Funds IV Ltd.

     

      I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY):

      00-0000000

      2  

      CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)

      (a)  ☐        (b)  ☒ (1)

     

      3  

      SEC USE ONLY

     

      4  

      CITIZENSHIP OR PLACE OF ORGANIZATION

     

      Israel

    NUMBER OF

    SHARES

     BENEFICIALLY 

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH

       5    

      SOLE VOTING POWER

     

      0

       6  

      SHARED VOTING POWER

     

      77,300

       7  

      SOLE DISPOSITIVE POWER

     

      0

       8  

      SHARED DISPOSITIVE POWER

     

      77,300

      9    

      AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

      77,300

    10  

      CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)

     

      ☐

    11  

      PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

     

      0.1% (2)

    12  

      TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)

     

      OO

     

    (1)

    This Schedule 13G is filed on behalf of Gemini Israel V Limited Partnership (“Gemini V”), Gemini Capital Associates V LP (“Gemini Associates LP”), Gemini Capital Associates V GP, Ltd. (“Gemini Associates GP”), Gemini Partners Investors V L.P. (“Gemini Partners”), Gemini Israel Funds IV Ltd. (“Gemini Israel”), Menashe Ezra (“Ezra”) and Yossi Sela (“Sela”) (collectively, the “Reporting Persons”). Gemini Associates GP is the general partner of Gemini Associates LP, which is the general partner of Gemini V, and each of Gemini Associates GP and Gemini Associates LP may be deemed to beneficially own the ordinary shares of the issuer held by Gemini V. Gemini Israel is the general partner of Gemini Partners and may be deemed to beneficially own the ordinary shares of the issuer held by Gemini Partners. Ezra and Sela are the managing partners of Gemini Associates GP and Gemini Israel, and each of Ezra and Sela may therefore be deemed to beneficially own the ordinary shares of the issuer held by Gemini V and Gemini Partners. Each of Gemini Associates GP, Gemini Associates LP, Germini Israel, Ezra and Sela hereby disclaims beneficial ownership of the ordinary shares of the issuer held by Gemini V and Gemini Partners except to the extent of its or his pecuniary interest therein. The Reporting Persons may be deed to a be a “group” for purposes of Section 13 of the Securities and Exchange Act of 1934 and hereby expressly disclaim status as a “group” for purposes of this Schedule 13G.

    (2)

    Based on 83,754,006 of the Issuer’s ordinary shares outstanding as of December 31, 2021, as reported in the Issuer’s Annual Report on Form 20-F for the annual period ended December 31, 2021, filed with the Securities and Exchange Commission on March 24, 2022.


    CUSIP NO. M97628107    13 G    Page 7 of 12 Pages

     

      1    

      NAMES OF REPORTING PERSONS

      Menashe Ezra

     

      I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY):

     

      2  

      CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)

      (a)  ☐        (b)  ☒ (1)

     

      3  

      SEC USE ONLY

     

      4  

      CITIZENSHIP OR PLACE OF ORGANIZATION

     

      Israel

    NUMBER OF

    SHARES

     BENEFICIALLY 

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH

       5    

      SOLE VOTING POWER

     

      0

       6  

      SHARED VOTING POWER

     

      7,730,048

       7  

      SOLE DISPOSITIVE POWER

     

      0

       8  

      SHARED DISPOSITIVE POWER

     

      7,730,048

      9    

      AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

      7,730,048

    10  

      CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)

     

      ☐

    11  

      PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

     

      9.2% (2)

    12  

      TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)

     

      IN

     

    (1)

    This Schedule 13G is filed on behalf of Gemini Israel V Limited Partnership (“Gemini V”), Gemini Capital Associates V LP (“Gemini Associates LP”), Gemini Capital Associates V GP, Ltd. (“Gemini Associates GP”), Gemini Partners Investors V L.P. (“Gemini Partners”), Gemini Israel Funds IV Ltd. (“Gemini Israel”), Menashe Ezra (“Ezra”) and Yossi Sela (“Sela”) (collectively, the “Reporting Persons”). Gemini Associates GP is the general partner of Gemini Associates LP, which is the general partner of Gemini V, and each of Gemini Associates GP and Gemini Associates LP may be deemed to beneficially own the ordinary shares of the issuer held by Gemini V. Gemini Israel is the general partner of Gemini Partners and may be deemed to beneficially own the ordinary shares of the issuer held by Gemini Partners. Ezra and Sela are the managing partners of Gemini Associates GP and Gemini Israel, and each of Ezra and Sela may therefore be deemed to beneficially own the ordinary shares of the issuer held by Gemini V and Gemini Partners. Each of Gemini Associates GP, Gemini Associates LP, Germini Israel, Ezra and Sela hereby disclaims beneficial ownership of the ordinary shares of the issuer held by Gemini V and Gemini Partners except to the extent of its or his pecuniary interest therein. The Reporting Persons may be deed to a be a “group” for purposes of Section 13 of the Securities and Exchange Act of 1934 and hereby expressly disclaim status as a “group” for purposes of this Schedule 13G.

    (2)

    Based on 83,754,006 of the Issuer’s ordinary shares outstanding as of December 31, 2021, as reported in the Issuer’s Annual Report on Form 20-F for the annual period ended December 31, 2021, filed with the Securities and Exchange Commission on March 24, 2022.


    CUSIP NO. M97628107    13 G    Page 8 of 12 Pages

     

      1    

      NAMES OF REPORTING PERSONS

      Yossi Sela

     

      I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY):

     

      2  

      CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)

      (a)  ☐        (b)  ☒ (1)

     

      3  

      SEC USE ONLY

     

      4  

      CITIZENSHIP OR PLACE OF ORGANIZATION

     

      Israel

    NUMBER OF

    SHARES

     BENEFICIALLY 

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH

       5    

      SOLE VOTING POWER

     

      0

       6  

      SHARED VOTING POWER

     

      7,730,048

       7  

      SOLE DISPOSITIVE POWER

     

      0

       8  

      SHARED DISPOSITIVE POWER

     

      7,730,048

      9    

      AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

      7,730,048

    10  

      CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)

     

      ☐

    11  

      PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

     

      9.2% (3)

    12  

      TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)

     

      IN

     

    (1)

    This Schedule 13G is filed on behalf of Gemini Israel V Limited Partnership (“Gemini V”), Gemini Capital Associates V LP (“Gemini Associates LP”), Gemini Capital Associates V GP, Ltd. (“Gemini Associates GP”), Gemini Partners Investors V L.P. (“Gemini Partners”), Gemini Israel Funds IV Ltd. (“Gemini Israel”), Menashe Ezra (“Ezra”) and Yossi Sela (“Sela”) (collectively, the “Reporting Persons”). Gemini Associates GP is the general partner of Gemini Associates LP, which is the general partner of Gemini V, and each of Gemini Associates GP and Gemini Associates LP may be deemed to beneficially own the ordinary shares of the issuer held by Gemini V. Gemini Israel is the general partner of Gemini Partners and may be deemed to beneficially own the ordinary shares of the issuer held by Gemini Partners. Ezra and Sela are the managing partners of Gemini Associates GP and Gemini Israel, and each of Ezra and Sela may therefore be deemed to beneficially own the ordinary shares of the issuer held by Gemini V and Gemini Partners. Each of Gemini Associates GP, Gemini Associates LP, Germini Israel, Ezra and Sela hereby disclaims beneficial ownership of the ordinary shares of the issuer held by Gemini V and Gemini Partners except to the extent of its or his pecuniary interest therein. The Reporting Persons may be deed to a be a “group” for purposes of Section 13 of the Securities and Exchange Act of 1934 and hereby expressly disclaim status as a “group” for purposes of this Schedule 13G.

    (2)

    Based on 83,754,006 of the Issuer’s ordinary shares outstanding as of December 31, 2021, as reported in the Issuer’s Annual Report on Form 20-F for the annual period ended December 31, 2021, filed with the Securities and Exchange Commission on March 24, 2022.


    CUSIP NO. M97628107    13 G    Page 9 of 12 Pages

     

    Item 1(a)    Name of Issuer:
       WalkMe Ltd.
    Item 1(b)    Address of Issuer’s principal executive offices:
       1 Walter Moses Street
       Tel Aviv, 6789903, Israel
    Items 2(a)    Name of Reporting Persons filing:
       Each of the following is a reporting person (“Reporting Person”):
       Gemini Israel V Limited Partnership
       Gemini Capital Associates V L.P.
       Gemini Capital Associates V GP Ltd.
       Gemini Partners Investors V L.P.
       Gemini Israel Funds IV Ltd.
       Menashe Ezra
       Yossi Sela
    Item 2(b)    Address or principal business office or, if none, residence:
       The principal business address of each Reporting Person is:
       c/o Gemini Israel Ventures
       1 Abba Eban Avenue
       Merkazim 2001, Bldg A, 3rd Floor
       Herzliya Israel
    Item 2(c)    Citizenship:
       Reference is made to the response to item 4 on each of pages 2-8 of this Schedule 13G (this “Schedule”), which responses are incorporated herein by reference.
    Item 2(d)    Title of class of securities:
       Ordinary Shares
    Item 2(e)    CUSIP No.:
       M97628107
    Item 3    If this statement is filed pursuant to §§ 240.13d-1(b), or 240.13d-2(b) or (c), check whether the person filings is a:
       Not applicable.
    Item 4    Ownership
       Reference is hereby made to the responses to items 5-9 and 11 of pages 2—8 of this Schedule, which responses are incorporated by reference herein.


    CUSIP NO. M97628107    13 G    Page 10 of 12 Pages

     

       Gemini Capital Associates V LP (Gemini Associates LP) is the general partner of Gemini Israel V Limited Partnership (Gemini V) and Gemini Capital Associates V GP, Ltd. (Gemini Associates GP) is the general partner of Gemini Associates LP. Gemini Israel Funds IV Ltd. (Gemini Israel) is the general partner of Gemini Partners Investors V L.P. (Gemini Partners). Menashe Ezra and Yossi Sela are the managing partners of Gemini Associates GP and Gemini Israel. Each of Gemini Associates LP, Gemini Associates GP, Gemini Israel, Ezra and Sela hereby disclaims beneficial ownership of the ordinary shares held by Gemini V and Gemini Partners except to the extent of its or his pecuniary interest therein.
    Item 5    Ownership of Five Percent or Less of a Class
       If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following: ☐
    Item 6    Ownership of More than Five Percent on Behalf of Another Person
       Not applicable.
    Item 7    Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person
       Not applicable.
    Item 8    Identification and Classification of Members of the Group
       Not applicable.
    Item 9    Notice of Dissolution of Group
       Not applicable.
    Item 10    Certifications
       Not applicable.


    SIGNATURES

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

    Dated: February 9, 2023

     

    GEMINI ISRAEL V LIMITED PARTNERSHIP
    By: GEMINI CAPITAL ASSOCIATES V GP LTD.
    Its: General Partner      
    By:  

    /s/ Yossi Sela

        By:  

    /s/ Menashe Ezra

    Name:   Yossi Sela     Name:   Menashe Ezra
    Title:   Managing Partner     Title:   Managing Partner
    GEMINI CAPITAL ASSOCIATES V L.P.  
    By: GEMINI CAPITAL ASSOCIATES V GP LTD.
    Its: General Partner      
    By:  

    /s/ Yossi Sela

        By:  

    /s/ Menashe Ezra

    Name:   Yossi Sela     Name:   Menashe Ezra
    Title:   Managing Partner     Title:   Managing Partner
    GEMINI CAPITAL ASSOCIATES V GP LTD.
    By:  

    /s/ Yossi Sela

        By:  

    /s/ Menashe Ezra

    Name:   Yossi Sela     Name:   Menashe Ezra
    Title:   Managing Partner     Title:   Managing Partner
    GEMINI PARTNERS INVESTORS V L.P.
    By: GEMINI ISRAEL FUNDS IV, LTD.  
    Its: General Partner      
    By:  

    /s/ Yossi Sela

        By:  

    /s/ Menashe Ezra

    Name:   Yossi Sela     Name:   Menashe Ezra
    Title:   Managing Partner     Title:   Managing Partner


    GEMINI ISRAEL FUNDS IV LTD.  
    By:  

    /s/ Yossi Sela

        By:  

    /s/ Menashe Ezra

    Name:   Yossi Sela     Name:   Menashe Ezra
    Title:   Managing Partner     Title:   Managing Partner

    /s/ Menashe Ezra

         
    Menashe Ezra      

    /s/ Yossi Sela

         
    Yossi Sela      
    Get the next $WKME alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $WKME

    DatePrice TargetRatingAnalyst
    3/21/2024Sector Weight
    KeyBanc Capital Markets
    1/12/2024$10.00Equal Weight → Underweight
    Barclays
    5/8/2023$13.00 → $11.00Outperform → Market Perform
    BMO Capital Markets
    1/12/2023$12.00 → $11.00Buy → Neutral
    Citigroup
    10/18/2022$15.00 → $9.00Overweight → Equal Weight
    Barclays
    6/7/2022$13.00Equal-Weight
    Morgan Stanley
    5/24/2022Overweight → Sector Weight
    KeyBanc Capital Markets
    4/27/2022$23.00Buy
    Goldman
    More analyst ratings

    $WKME
    SEC Filings

    See more
    • SEC Form 15-12G filed by WalkMe Ltd.

      15-12G - WalkMe Ltd. (0001847584) (Filer)

      9/23/24 6:02:22 AM ET
      $WKME
      Computer Software: Prepackaged Software
      Technology
    • SEC Form S-8 POS filed by WalkMe Ltd.

      S-8 POS - WalkMe Ltd. (0001847584) (Filer)

      9/12/24 9:27:42 AM ET
      $WKME
      Computer Software: Prepackaged Software
      Technology
    • SEC Form S-8 POS filed by WalkMe Ltd.

      S-8 POS - WalkMe Ltd. (0001847584) (Filer)

      9/12/24 9:25:34 AM ET
      $WKME
      Computer Software: Prepackaged Software
      Technology

    $WKME
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • KeyBanc Capital Markets initiated coverage on WalkMe Ltd.

      KeyBanc Capital Markets initiated coverage of WalkMe Ltd. with a rating of Sector Weight

      3/21/24 8:06:25 AM ET
      $WKME
      Computer Software: Prepackaged Software
      Technology
    • WalkMe Ltd. downgraded by Barclays with a new price target

      Barclays downgraded WalkMe Ltd. from Equal Weight to Underweight and set a new price target of $10.00

      1/12/24 7:01:16 AM ET
      $WKME
      Computer Software: Prepackaged Software
      Technology
    • WalkMe Ltd. downgraded by BMO Capital Markets with a new price target

      BMO Capital Markets downgraded WalkMe Ltd. from Outperform to Market Perform and set a new price target of $11.00 from $13.00 previously

      5/8/23 7:34:01 AM ET
      $WKME
      Computer Software: Prepackaged Software
      Technology

    $WKME
    Financials

    Live finance-specific insights

    See more
    • WalkMe Announces Date of First Quarter 2024 Financial Results and Conference Call

      SAN FRANCISCO, May 08, 2024 (GLOBE NEWSWIRE) -- WalkMe Ltd. (NASDAQ:WKME), a leading provider of digital adoption solutions, today announced it will release its first quarter and full year 2024 financial results before U.S. markets open on Wednesday, May 22, 2024. WalkMe will host a webcast that day at 5:00 a.m. Pacific Time (8:00 a.m. Eastern Time) to discuss its business and financial performance. First Quarter Financial Results and Conference Call Date: Wednesday, May 22, 2024 Time: 5:00 a.m. Pacific Time / 8:00 a.m. Eastern Time Webcast: https://ir.walkme.com Dial-in: U.S. Toll Free: (646) 876 9923; International: +972 3 978 6688; Webinar ID: 982 8017 7604 Approximately one hour

      5/8/24 9:08:25 AM ET
      $WKME
      Computer Software: Prepackaged Software
      Technology
    • WalkMe Announces Date of Fourth Quarter and Full Year 2023 Financial Results and Conference Call

      SAN FRANCISCO, Feb. 06, 2024 (GLOBE NEWSWIRE) -- WalkMe Ltd. (NASDAQ:WKME), a leading provider of digital adoption solutions, today announced it will release its fourth quarter and full year 2023 financial results before U.S. markets open on Wednesday, February 21, 2024. WalkMe will host a webcast that day at 5:00 a.m. Pacific Time (8:00 a.m. Eastern Time) to discuss its business and financial performance. Fourth Quarter and Full Year Financial Results and Conference CallDate: Wednesday, February 21, 2024Time: 5:00 a.m. Pacific Time / 8:00 a.m. Eastern TimeWebcast: https://ir.walkme.comDial-in: U.S. Toll Free: (646) 876 9923; International: +972 3 978 6688; Webinar ID: 984 8786 6110Approx

      2/6/24 8:00:00 AM ET
      $WKME
      Computer Software: Prepackaged Software
      Technology
    • WalkMe Ltd. Announces Third Quarter 2023 Financial Results

      Achieved a record Non-GAAP operating income ahead of plan of $1.6M compared to a loss of ($12.5M) last year and GAAP operating loss of ($11.6M) compared to ($26.4M) last year.Non-GAAP Net income Per Share of $0.04 and GAAP Net Loss Per Share of ($0.10).Continued positive Free Cash Flow of $6.2M and 9% FCF margin. SAN FRANCISCO, Nov. 14, 2023 (GLOBE NEWSWIRE) -- WalkMe Ltd. (NASDAQ:WKME), a leading provider of digital adoption solutions, today announced financial results for its third quarter ended September 30, 2023. Management Commentary "Q3 was a milestone quarter as WalkMe achieved our goal of reaching profitability ahead of schedule. We believe our investments in our strategic growt

      11/14/23 7:00:00 AM ET
      $WKME
      Computer Software: Prepackaged Software
      Technology

    $WKME
    Leadership Updates

    Live Leadership Updates

    See more
    • SAP Enters into Agreement to Acquire WalkMe, Driving Business Transformation by Enhancing the Customer Experience and Enriching SAP Business AI Offerings

      WALLDORF, Germany, June 5, 2024 /PRNewswire/ -- SAP SE (NYSE:SAP) and WalkMe Ltd. (NASDAQ:WKME) announced today that the companies have entered into a definitive agreement under which SAP will acquire WalkMe, a leader in digital adoption platforms (DAPs). WalkMe's solutions help organizations navigate constant technology change by providing users with advanced guidance and automation features that enable them to execute workflows seamlessly across any number of applications. This results in higher adoption of the underlying application and as such drives value realization. The

      6/5/24 5:00:00 AM ET
      $SAP
      $WKME
      Computer Software: Prepackaged Software
      Technology
    • WalkMe Announces Key Leadership Appointment to Meet Continued Accelerated Digital Adoption Demand in EMEA

      LONDON, Nov. 13, 2023 (GLOBE NEWSWIRE) -- WalkMe Inc. (NASDAQ:WKME), a leading provider of digital adoption solutions, today announced the appointment of Ofir Hatsor as Senior Vice President of EMEA Sales. The new regional sales leader will take on the increasing demand for WalkMe's best in class Digital Adoption Platform (DAP) as businesses across industries seek to maximize the value from their software investments while boosting productivity and providing seamless user experiences, aligning with the 3.7% rise in IT spending across EMEA, as forecasted by Gartner for 2023. "WalkMe continues to provide incredible value to organizations around the globe," said Dan Adika, CEO & Co-founder o

      11/13/23 9:00:00 AM ET
      $WKME
      Computer Software: Prepackaged Software
      Technology
    • WalkMe Launches Propel Partner Program to Support Growing Demand for Digital Adoption Technology Worldwide

      SAN FRANCISCO, Oct. 23, 2023 (GLOBE NEWSWIRE) -- WalkMe Inc. (NASDAQ:WKME), a leading provider of digital adoption solutions, today announced Propel, a new partner program tailored to give global and regional services integrators as well as ISV/tech alliance partners a head-start in harnessing the rapidly-expanding Digital Adoption Platform (DAP) market. The new experience of the program offers existing and new partners the foundation to unlock enterprise-scale revenue streams delivering consistently brilliant, personalized, and responsive digital experiences for joint customers. Propel allows participants to join WalkMe's growing ecosystem of hundreds of partners. Offering four levels

      10/23/23 8:55:00 AM ET
      $WKME
      Computer Software: Prepackaged Software
      Technology

    $WKME
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Enterprises wasted $104M on underused tech in 2024 while 75% of workers struggle to harness AI efficiencies, new WalkMe research finds

      SAN FRANCISCO, Feb. 25, 2025 (GLOBE NEWSWIRE) -- WalkMe, the leader of the Digital Adoption Platform (DAP) category for effectively navigating technology change, today released its annual report, The State of Digital Adoption 2025, Special AI Edition. This year's report focuses on AI adoption in the enterprise and highlights an alarming disconnect – while 79% of executives express confidence in meeting their AI transformation goals, only 28% of employees feel adequately trained and only 25% report being able to use AI to work more efficiently. The report uncovers the staggering cost of digital inefficiencies, with enterprises losing over $104 million in 2024 alone due to underutilized tec

      2/25/25 9:00:00 AM ET
      $WKME
      Computer Software: Prepackaged Software
      Technology
    • Category Creator WalkMe Recognized As The "AI-Powered DAP for the Enterprise" In Industry Analyst Report

      SAN FRANCISCO, Nov. 26, 2024 (GLOBE NEWSWIRE) -- WalkMe, the leader of the Digital Adoption Platform (DAP) category for effectively navigating technology change, today announced it was recognized as a leader in The Forrester Wave™: Digital Adoption Platforms (DAP), 2024. The recognition validates WalkMe's AI-first approach, which is further strengthened by its fall '24 product release introducing enhanced enterprise-grade AI capabilities and scalability features. "WalkMe is the category builder for DAPs," the Forrester report authored by Principal Analyst at Forrester Research, Vasupradha Srinivasan notes: "The firm leads with its commitment to be AI-first across the platform, which is re

      11/26/24 9:00:00 AM ET
      $WKME
      Computer Software: Prepackaged Software
      Technology
    • SAP Completes Acquisition of WalkMe

      WALLDORF, Sept. 12, 2024 (GLOBE NEWSWIRE) -- SAP SE (NYSE:SAP) today announced it has successfully completed its acquisition of WalkMe Ltd., a leading digital adoption platform company listed on the Nasdaq Global Select Market (NASDAQ:WKME). WalkMe's innovative technology enables seamless workflow execution across business software applications, improving user experience and adoption and supporting business transformation. WalkeMeX's AI capabilities will supercharge SAP's copilot Joule with context-aware and proactive help across workflows, allowing users to become more productive. As a result of the acquisition, each ordinary issued and outstanding share of WalkMe Ltd. has been converted

      9/12/24 9:05:19 AM ET
      $SAP
      $WKME
      Computer Software: Prepackaged Software
      Technology

    $WKME
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13D/A filed by WalkMe Ltd.

      SC 13D/A - WalkMe Ltd. (0001847584) (Subject)

      9/16/24 1:05:48 PM ET
      $WKME
      Computer Software: Prepackaged Software
      Technology
    • SEC Form SC 13G/A filed by WalkMe Ltd. (Amendment)

      SC 13G/A - WalkMe Ltd. (0001847584) (Subject)

      2/13/24 1:23:55 PM ET
      $WKME
      Computer Software: Prepackaged Software
      Technology
    • SEC Form SC 13G/A filed by WalkMe Ltd. (Amendment)

      SC 13G/A - WalkMe Ltd. (0001847584) (Subject)

      2/13/24 10:58:49 AM ET
      $WKME
      Computer Software: Prepackaged Software
      Technology